Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Condition: OSA Interventions: Drug: Atomoxetine 80 mg plus Oxybutynin 5 mg; Drug: Atomoxetine 80 MG; Drug: Placebo Sponsor: Brigham and Women's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Obstructive Sleep Apnea | Oxybutynin | Research | Sleep Apnea | Sleep Disorders | Sleep Medicine | Strattera | Women